• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胶质瘤侵袭性的分子机制:蛋白酶的作用

Molecular mechanisms of glioma invasiveness: the role of proteases.

作者信息

Rao Jasti S

机构信息

Program of Cancer Biology, Department of Neurosurgery, University of Illinois College of Medicine-Peoria, 1 Illini Drive, Peoria, Illinois 61656, USA.

出版信息

Nat Rev Cancer. 2003 Jul;3(7):489-501. doi: 10.1038/nrc1121.

DOI:10.1038/nrc1121
PMID:12835669
Abstract

The invasive nature of brain-tumour cells makes an important contribution to the ineffectiveness of current treatment modalities, as the remaining tumour cells inevitably infiltrate the surrounding normal brain tissue, which leads to tumour recurrence. Such local invasion remains an important cause of mortality and underscores the need to understand in more detail the mechanisms of tumour invasiveness. Several proteases influence the malignant characteristics of gliomas--could their inhibition prove to be a useful therapeutic strategy?

摘要

脑肿瘤细胞的侵袭性是导致当前治疗方式效果不佳的一个重要因素,因为残留的肿瘤细胞不可避免地会浸润周围正常脑组织,进而导致肿瘤复发。这种局部侵袭仍然是一个重要的致死原因,凸显了更详细了解肿瘤侵袭机制的必要性。几种蛋白酶会影响胶质瘤的恶性特征——抑制这些蛋白酶能否成为一种有效的治疗策略呢?

相似文献

1
Molecular mechanisms of glioma invasiveness: the role of proteases.胶质瘤侵袭性的分子机制:蛋白酶的作用
Nat Rev Cancer. 2003 Jul;3(7):489-501. doi: 10.1038/nrc1121.
2
Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis.来自双顺反子腺病毒构建体的反义uPAR和反义uPA的表达抑制胶质瘤细胞侵袭、肿瘤生长和血管生成。
Oncogene. 2003 Sep 4;22(38):5967-75. doi: 10.1038/sj.onc.1206535.
3
Expression of matrix metalloproteinases-1, -2, and -9; tissue inhibitors of matrix metalloproteinases-1 and -2; cathepsin B; urokinase plasminogen activator; and plasminogen activator inhibitor, type I in skull base chordoma.基质金属蛋白酶-1、-2和-9;基质金属蛋白酶组织抑制剂-1和-2;组织蛋白酶B;尿激酶型纤溶酶原激活物;以及I型纤溶酶原激活物抑制剂在颅底脊索瘤中的表达
Hum Pathol. 2008 Feb;39(2):217-23. doi: 10.1016/j.humpath.2007.06.005. Epub 2007 Oct 18.
4
RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas.RNA干扰介导的组织蛋白酶B和尿激酶型纤溶酶原激活物受体抑制导致神经胶质瘤细胞侵袭、血管生成和肿瘤生长减少。
Oncogene. 2004 Nov 4;23(52):8486-96. doi: 10.1038/sj.onc.1207879.
5
Exploitation of astrocytes by glioma cells to facilitate invasiveness: a mechanism involving matrix metalloproteinase-2 and the urokinase-type plasminogen activator-plasmin cascade.胶质瘤细胞利用星形胶质细胞促进侵袭:一种涉及基质金属蛋白酶-2和尿激酶型纤溶酶原激活物-纤溶酶级联反应的机制。
J Neurosci. 2003 May 15;23(10):4034-43. doi: 10.1523/JNEUROSCI.23-10-04034.2003.
6
Proteases in brain tumour progression.脑肿瘤进展中的蛋白酶
Acta Neurochir (Wien). 2003 Sep;145(9):825-38. doi: 10.1007/s00701-003-0097-z.
7
Downregulation of the RECK-tumor and metastasis suppressor gene in glioma invasiveness.RECK肿瘤及转移抑制基因下调在胶质瘤侵袭中的作用
J Cell Biochem. 2006 Sep 1;99(1):156-67. doi: 10.1002/jcb.20917.
8
The role of proteolysis in tumor invasiveness in glioblastoma and metastatic brain tumors.蛋白水解在胶质母细胞瘤和转移性脑肿瘤的肿瘤侵袭中的作用。
Anticancer Res. 2002 Nov-Dec;22(6C):4265-8.
9
Stimulation of human breast carcinoma cell invasiveness and urokinase plasminogen activator activity by glucose deprivation.葡萄糖剥夺对人乳腺癌细胞侵袭性及尿激酶型纤溶酶原激活物活性的刺激作用。
Exp Cell Res. 2006 Jun 10;312(10):1685-92. doi: 10.1016/j.yexcr.2006.02.004. Epub 2006 Mar 27.
10
Proteases and their inhibitors in human brain tumours: a review.人脑肿瘤中的蛋白酶及其抑制剂:综述
Anticancer Res. 1997 Nov-Dec;17(6B):4151-62.

引用本文的文献

1
The Role of Pyk2 Kinase in Glioblastoma Progression and Therapeutic Targeting.Pyk2激酶在胶质母细胞瘤进展及治疗靶向中的作用
Cancers (Basel). 2025 Aug 9;17(16):2611. doi: 10.3390/cancers17162611.
2
Synthesis and Characterization of Transferrin Receptor-Targeted Peptide Combination SN-38 and Rucaparib Conjugate for the Treatment of Glioblastoma.转铁蛋白受体靶向肽组合SN-38与鲁卡帕尼偶联物的合成与表征用于胶质母细胞瘤治疗
Pharmaceutics. 2025 Jun 2;17(6):732. doi: 10.3390/pharmaceutics17060732.
3
Exploring tumor-associated macrophages in glioblastoma: from diversity to therapy.
探索胶质母细胞瘤中肿瘤相关巨噬细胞:从多样性到治疗
NPJ Precis Oncol. 2025 May 2;9(1):126. doi: 10.1038/s41698-025-00920-x.
4
Current and Future Applications of 5-Aminolevulinic Acid in Neurosurgical Oncology.5-氨基乙酰丙酸在神经外科肿瘤学中的当前及未来应用
Cancers (Basel). 2025 Apr 15;17(8):1332. doi: 10.3390/cancers17081332.
5
Autologous gradient formation under differential interstitial fluid flow environments.在不同的组织间液流动环境下的自体梯度形成。
Biophysica. 2022 Mar;2(1):16-33. doi: 10.3390/biophysica2010003. Epub 2022 Jan 4.
6
Actuated Hydrogel Platforms To Study Brain Cell Behavior.用于研究脑细胞行为的驱动水凝胶平台
Adv Healthc Mater. 2025 Apr;14(10):e2404484. doi: 10.1002/adhm.202404484. Epub 2025 Mar 16.
7
Protease regulation of tumor-immune cell symbiosis.蛋白酶对肿瘤-免疫细胞共生关系的调节
Trends Cancer. 2025 Jun;11(6):560-574. doi: 10.1016/j.trecan.2025.02.004. Epub 2025 Mar 8.
8
Emerging Approaches in Glioblastoma Treatment: Modulating the Extracellular Matrix Through Nanotechnology.胶质母细胞瘤治疗的新兴方法:通过纳米技术调节细胞外基质
Pharmaceutics. 2025 Jan 21;17(2):142. doi: 10.3390/pharmaceutics17020142.
9
Glioblastoma-derived migrasomes promote migration and invasion by releasing PAK4 and LAMA4.胶质母细胞瘤来源的迁移小体通过释放PAK4和LAMA4促进迁移和侵袭。
Commun Biol. 2025 Jan 20;8(1):91. doi: 10.1038/s42003-025-07526-w.
10
Nanostructured lipid carriers for enhanced batimastat delivery across the blood-brain barrier: an in vitro study for glioblastoma treatment.用于增强巴替麦司他透过血脑屏障递送的纳米结构脂质载体:一项针对胶质母细胞瘤治疗的体外研究
Drug Deliv Transl Res. 2025 Jan 6. doi: 10.1007/s13346-024-01775-8.